A high-throughput absorbance-based assay for methionine produced by methionine aminopeptidase using S-adenosyl-L-methionine synthetase

Methionine aminopeptidase (MAP) (E.C. 3.4.11.18) is a metallopeptidase that cleaves the N-terminal methionine (Met) residue from some proteins. MAP is essential for growth of several bacterial pathogens, making it a target for antibacterial drug discovery. MAP enzymes are also present in eukaryotic cells, and one is a target for antiangiogenic cancer therapy. To screen large compound libraries for MAP inhibitors as the starting point for drug discovery, a high-throughput-compatible assay is valuable. Here the authors describe a novel assay, which detects the Met product of MAP-catalyzed peptide cleavage by coupling it to adenosine triphosphate (ATP)-dependent production of S-adenosyl-L-methionine (SAM) and inorganic phosphate (P(i)) by SAM synthetase (MetK) combined with inorganic pyrophosphatase. The three P(i) ions produced for each Met consumed are detected using Malachite Green/molybdate reagent. This assay can use any unmodified peptide MAP substrate with an N-terminal Met. The assay was used to measure kinetic constants for Escherichia coli MAP using Mn(2+) as the activator and the peptide Met-Gly-Met-Met as the substrate, as well as to measure the potency of a MAP inhibitor. A Mn(2+) buffer is described that can be used to prevent free Mn(2+) depletion by chelating compounds from interfering in screens for MAP inhibitors.     

Detection of advanced oxidation protein products in patients with chronic kidney disease by a novel monoclonal antibody

Advanced oxidation protein products (AOPP) as a biomarker of oxidative stress has been demonstrated in chronic kidney disease (CKD) patients; however, current methods to detect the accumulation of AOPP in serum and in tissues are limited and unreliable. This study generated a monoclonal antibody (mAb) designated 3F2, that reacts specifically with hypochlorous acid (HOCl)-modified proteins, but not with the native forms or with other types of oxidative modifications. Notably, mAb 3F2 recognizes the AOPP deposited in renal tissues of AOPP-treated rats and of patients with different kinds of CKD. Moreover, this mAb can almost completely inhibit the production of reactive oxygen species in RAW264.7 cells induced by AOPP (p < 0.001). In conclusion, mAb 3F2 can be used to detect AOPP specifically in serum and in tissues, and this antibody can potentially provide an important tool and new insight into research on diseases related to oxidative stress.     

A genome-wide association study confirms previously reported loci for type 2 diabetes in Han Chinese

Background

Genome-wide association study (GWAS) has identified more than 30 loci associated with type 2 diabetes (T2D) in Caucasians. However, genomic understanding of T2D in Asians, especially Han Chinese, is still limited.

Methods and Principal Findings

A two-stage GWAS was performed in Han Chinese from Mainland China. The discovery stage included 793 T2D cases and 806 healthy controls genotyped using Illumina Human 660- and 610-Quad BeadChips; and the replication stage included two independent case-control populations (a total of 4445 T2D cases and 4458 controls) genotyped using TaqMan assay. We validated the associations of KCNQ1 (rs163182, p = 2.085×10⁻¹⁷, OR 1.28) and C2CD4A/B (rs1370176, p = 3.677×10⁻⁴, OR 1.124; rs1436953, p = 7.753×10⁻⁶, OR 1.141; rs7172432, p = 4.001×10⁻⁵, OR 1.134) in Han Chinese.

Conclusions and Significance

Our study represents the first GWAS of T2D with both discovery and replication sample sets recruited from Han Chinese men and women residing in Mainland China. We confirmed the associations of KCNQ1 and C2CD4A/B with T2D, with the latter for the first time being examined in Han Chinese. Arguably, eight more independent loci were replicated in our GWAS.     

CircHIPK3 prevents chondrocyte apoptosis and cartilage degradation by sponging miR‐30a‐3p and promoting PON2

Osteoarthritis (OA) is a common joint disease featured by the deterioration of articular cartilage and chondrocyte death. Emerging evidence has indicated that circular RNAs (circRNAs) play an essential role in OA progress. Here, we found that the expression of circHIPK3 was significantly decreased in human and mouse OA cartilage. Knocking down circHIPK3 increased apoptosis and intracellular ROS level in HC‐a chondrocytes. We performed proteomic studies and identified that circHIPK3 regulated chondrocyte apoptosis through the mitochondrial pathway. Results of JC‐1 staining and western blot further confirmed that mitochondrial outer membrane permeabilization was promoted in HC‐a chondrocytes transfected by circHIPK3 siRNA. In terms of mechanism, we showed that PON2 functioned as a potential target of circHIPK3 to regulate chondrocyte apoptosis. Moreover, we revealed that circHIPK3 interacted with miR‐30a‐3p to regulate PON2 expression in chondrocytes. Taken together, our findings suggested that circHIPK3 regulated chondrocyte apoptosis by mitochondrial pathway, and targeting the circHIPK3/miR‐30a‐3p/PON2 axis might be a potential strategy for OA treatment.

The current study revealed the important role of circHIPK3 in regulating chondrocyte apoptosis and maintaining extracellular matrix (ECM) homeostasis. Mechanistically, circHIIPK3 might serve as a sponge of miR‐30a‐3p to regulate PON2 expression. The downregulation of circHIIPK3 resulted in the increased expression of miR‐30a‐3p and decreased expression of PON2, thus leading to mitochondrial pathway apoptosis and ECM destruction.     

积雪变化对陆地生态系统植被特征和土壤碳氮过程的影响

在季节性积雪地区,冬季气候变暖导致积雪变薄、积雪不连续、融雪提前及雪盖面积缩小等现象。然而相较于氮沉降、增温、降水变化等全球变化因子,目前尚缺乏积雪因子对陆地生态系统过程和功能影响的系统报道。为加深人们对积雪特征变化生态后果的认知,综述了积雪深度和融雪时间变化对植被物候和群落组成、凋落物分解、土壤碳氮过程、温室气体排放和土壤微食物网(土壤动物和微生物)的影响。由于模拟积雪变化手段不同和复杂的气候、土壤背景,生态系统各要素对积雪特征变化的响应规律存在较大的分异和不确定性。例如,在未来气候变暖导致积雪变薄和融雪提前情景下,植被物候提前,生长季延长,导致生产力增加和凋落物数量增加,禾草比例减少导致凋落物质量增加,早春温度高刺激微生物活性,凋落物分解速率高,促进土壤碳氮周转过程。但积雪减少和融雪提前导致的早春低温和夏季干旱也可能引起植被生产力下降,凋落物数量减少质量降低,土壤微生物活性低,分解速率低,从而减缓碳氮周转过程。此外,积雪特征变化对植被特征和土壤碳氮过程影响相关研究目前还存在以下问题：1)积雪深度和融雪时间对生态系统的影响是否存在交互效应仍缺乏关注,且积雪变化对后续生长季是否存在持续...     

山东莱阳晚白垩世鸭嘴龙动物群化石特异埋藏初步研究

近年来对位于莱阳棘鼻青岛龙发现地点(1号化石地点)以东新发现的2号化石地点进行大规模发掘,已发现5个化石富集层,赋存的化石均以鸭嘴龙科为主,一部分个体可能代表栉龙亚科的成员,而另一部分个体归于赖氏龙亚科的棘鼻青岛龙。这些鸭嘴龙化石从个体大小上分别代表成年、亚成年和幼年晚期个体。化石富集层以灰绿色和褐红色含砂砾泥岩沉积为主,具有典型的泥石流沉积特征和骨骼埋藏特征,并具有两种主要的死亡和埋藏模式,即恐龙群体活着时遭遇泥石流被吞没集群死亡后,肢体在短距离搬运中被撕裂并迅速沉积掩埋,骨骼分散但完整,同一个体的骨骼相距不远;恐龙正常或经泥石流导致其非正常死亡后,部分遗体未被掩埋,经暴露软组织腐烂,被后续发生的泥石流卷入并二次搬运,最终埋藏,表现为分散但较完整的骨骼与破碎呈砾石磨圆状的骨骼共生保存。这些富集层的化石及其埋藏特征反映了生活在河湖边的鸭嘴龙动物群,在鸭嘴龙幼年晚期刚刚加入成年鸭嘴龙动物群后,被卷入突发的洪水泥石流导致其集群死亡并快速埋藏的事件。     

Oxidative and nitrative DNA damage in animals and patients with inflammatory diseases in relation to inflammation-related carcinogenesis

Infection and chronic inflammation are proposed to contribute to carcinogenesis through inflammation-related mechanisms. Infection with hepatitis C virus, Helicobacter pylori and the liver fluke, Opisthorchis viverrini (OV), are important risk factors for hepatocellular carcinoma (HCC), gastric cancer and cholangiocarcinoma, respectively. Inflammatory bowel diseases (IBDs) and oral diseases, such as oral lichen planus (OLP) and leukoplakia, are associated with colon carcinogenesis and oral squamous cell carcinoma (OSCC), respectively. We performed a double immunofluorescence labeling study and found that nitrative and oxidative DNA lesion products, 8-nitroguanine and 8-oxo-7,8-dihydro-2'-deoxyguanosine (8-oxodG), were formed and inducible nitric oxide synthase (iNOS) was expressed in epithelial cells and inflammatory cells at the site of carcinogenesis in humans and animal models. Antibacterial, antiviral and antiparasitic drugs dramatically diminished the formation of these DNA lesion markers and iNOS expression. These results suggest that oxidative and nitrative DNA damage occurs at the sites of carcinogenesis, regardless of etiology. Therefore, it is considered that excessive amounts of reactive nitrogen species produced via iNOS during chronic inflammation may play a key role in carcinogenesis by causing DNA damage. On the basis of our results, we propose that 8-nitroguanine is a promising biomarker to evaluate the potential risk of inflammation-mediated carcinogenesis.